H
Last Price
52 Week Range
HK$9.72 - HK$16.94
Next Earnings Date
-
Next Earnings Date
-
Last Price
Market Cap | HK$22.80B |
EV | HK$127.51B |
Shares Outstanding | 1.39B |
Beta | 0.59 |
Industry | Real Estate - Diversified |
Analyst Rating | - |
Analyst Target Price | - |
Number of Analysts | 0 |
P/E 2026E | - |
P/Revenue 2026E | - |
Revenue | |
EPS | |
Operating Cash Flow | |
Free Cash Flow |
Revenue | |
EPS | |
Operating Cash Flow | |
Free Cash Flow |
Gross Margin 2026E | - |
Net Profit Margin 2026E | - |
ROE 2026E | - |
ROCE 2025 | 1.41% |
DPS 2026E | - |
Payout Ratio 2026E | - |
Div. Yield 2026E | - |
DPS Last 3Y CAGR |
Price
%
1M
3M
6M
1Y
3Y
5Y
H
Hang Lung Group Limited
10
Sector
Real Estate
Industry
Real Estate - Diversified
CEO
Lo, Wai Pak
Employees
4,595
Website
www.hanglung.comIPO Date
1972-10-12
Headquarters
Standard Chartered Bank Building, 28th Floor, 4 Des Voeux Road, Central Hong Kong
The current price of Hang Lung Group (10) is HK$16.67, reflecting a +0.42% change compared to the previous close. Last updated: February 15, 2026 at 9:43 PM Eastern Time
Review of Recent 10 Stock Performance trends:Past 1 Month: Hang Lung Group (10) shares changed by +2.47%.Past 3 Months: The stock recorded a change of +2.41%.Past 6 Months: 10 shares posted a change of +17.48%. Last updated: February 15, 2026 at 5:42 PM Eastern Time
Over the last year, Hang Lung Group (10) has established a 52-week price range between a high of HK$16.94 and a low of HK$9.72. This metric is essential for assessing the stock's annual volatility. Last updated: February 15, 2026 at 5:42 PM Eastern Time
Hang Lung Group (10) is considered a low volatility stock. It has a beta of 0.59, which means it typically moves 0.59 times as much as the broader market. Over the past 52 weeks, 10 has traded within a HK$9.72 – HK$16.94 range. Last updated: February 15, 2026 at 5:42 PM Eastern Time
A HK$1,000 investment in Hang Lung Group 5 years ago, when the stock was trading around HK$20.79, would be worth approximately HK$801.87 today, based solely on share price performance (excluding dividends). This represents a total return of -19.81% over the period, equivalent to a compound annual growth rate (CAGR) of -4.32%. Past performance reflects historical price movements only and does not imply future results. Last updated: February 15, 2026 at 5:42 PM Eastern Time
The current Hang Lung Group (10) market capitalization is approximately HK$22.80B, based on its latest share price and shares outstanding. Market capitalization represents the total market value of a company's equity and is calculated by multiplying the current stock price by the number of shares outstanding. As a result, Hang Lung Group's market cap fluctuates with changes in its share price and share count. Last updated: February 15, 2026 at 5:42 PM Eastern Time
In the most recently reported quarter, Hang Lung Group (10) generated HK$2.62B in revenue, representing a -3.13% year over year change. Quarterly revenue results and expectations reflect underlying demand trends, pricing dynamics, product or service mix, seasonality, and broader macroeconomic conditions. Actual results may differ from consensus estimates as new information becomes available. Last updated: February 15, 2026 at 5:10 AM Eastern Time
In the most recently reported fiscal year, Hang Lung Group (10) generated net income of HK$1.37B, compared with HK$1.61B in the prior fiscal year, representing a -15.07% year over year change. Net income may be positive or negative and can fluctuate materially from year to year due to changes in operating performance, non-recurring or one-time items, accounting treatments, capital structure, and broader macroeconomic conditions. Last updated: February 15, 2026 at 5:10 AM Eastern Time
According to its latest quarterly filing, Hang Lung Group (10) reported EBITDA of HK$1.58B, representing a +5.75% year over year change. EBITDA is a non-GAAP measure and does not account for depreciation, amortization, interest expense, taxes, or capital expenditures. As a result, it should be considered alongside other financial metrics when assessing operating performance. Actual results may differ from estimates as company-specific or macroeconomic conditions evolve. Last updated: February 15, 2026 at 5:10 AM Eastern Time
As of the most recent reporting period, the company's debt-to-equity ratio stands at 0.35x, calculated as total debt divided by total shareholders' equity. A lower debt-to-equity ratio generally indicates a more conservative capital structure with less reliance on external borrowing, while a higher ratio suggests greater financial leverage and potentially higher sensitivity to interest rates, refinancing conditions, and earnings volatility. The debt-to-equity ratio should be interpreted in the context of the company's industry, business model, cash flow stability, and balance sheet composition. Last updated: February 15, 2026 at 5:10 AM Eastern Time
Based on the latest available data, Hang Lung Group (10) is currently trading at a last twelve months (LTM) P/E ratio of 16.57x. The P/E ratio reflects how much investors are willing to pay today for a dollar of earnings and can vary meaningfully over time due to changes in profitability, growth expectations, margin outlook, and earnings volatility. Last updated: February 15, 2026 at 9:43 PM Eastern Time
In the most recently reported quarter, Hang Lung Group (10) revenue was HK$2.62B. Earnings per share (EPS) for the quarter were HK$0.25. Revenue and EPS surprises may be positive or negative and can influence near-term stock performance depending on expectations, forward guidance, and broader market and sector conditions. For a detailed history of analyst expectations versus reported results, view the full estimates vs. actuals track record here: 👉 Estimates vs. Actuals Last updated: February 15, 2026 at 5:10 AM Eastern Time
Based on the latest available analyst coverage, Hang Lung Group (10) currently carries a not available consensus rating. Analyst views are forward-looking estimates and should not be considered investment advice. Last updated: February 15, 2026 at 9:43 PM Eastern Time
Like other publicly traded stocks, Hang Lung Group (10) shares are bought and sold on stock exchanges such as SEHK and other supported markets, depending on the listing. The most common way to buy shares is through an online brokerage account. To get started, you typically need to: Open an account with a licensed stock brokerComplete the broker's verification processFund your accountPlace a buy order for Hang Lung Group (10) shares Trading involves risk, and investors should consider their financial objectives and risk tolerance before investing.
At the top right of this page, you'll see a star icon labeled Add to watchlist. Click it to add 10 to your watchlist.
Hang Lung Group trades under the ticker symbol 10 on the SEHK stock exchange. The ticker 10 is used to identify the company's common stock across trading platforms, market data providers, and regulatory filings.
As of the most recently reported period, Hang Lung Group (10) employs approximately 4,595 people worldwide. Reported employee figures may fluctuate over time due to hiring activity, restructuring, automation initiatives, or changes in business strategy. Headcount data is typically disclosed in company filings and reflects full-time employees unless otherwise stated. Last updated: February 15, 2026 at 5:42 PM Eastern Time
Hang Lung Group (10) operates in a highly competitive market with companies that often have different business models, geographic exposure, and end markets. While no two companies are identical, the following firms are generally considered the closest Hang Lung Group (10) stock peers based on overlapping products, services, and competitive dynamics:Azrieli Group (AZRG)Wharf Real Estate Investment (1997)Heimstaden (HEIM PREF)Red Star Macalline Group Corporation (1528)Alony-Hetz Properties & Investments (ALHE)Swire Properties (1972)Sunac Services Holdings (1516)Fastighets AB Balder (BALD B)CTP (CTPNV) These peers may differ in size, business mix, financial profile, and strategic focus, but they are commonly referenced due to overlapping markets, customer segments, or competitive positioning relative to Hang Lung Group.
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersNEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersGainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.